心力衰竭与肿瘤发生风险相关性研究进展  

Advances in the study of the association between heart failure and the risk of tumour development

作　　者：白盼盼 李春霞 卜星彭[1,2] 刘凡凡 刘永 陈还珍 Bai Panpan;Li Chunxia;Bu Xingpeng;Liu Fanfan;Liu Yong;Chen Huanzhen(Shanxi Medical University,Taiyuan 030012,China;Shanxi Bethune Hospital,Taiyuan 030032,China;First Hospital of Shanxi Medical University,Taiyuan 030001,China)

机构地区：[1]山西医科大学,太原030012 [2]山西白求恩医院,太原030032 [3]山西医科大学第一医院,太原030001

出　　处：《中华心力衰竭和心肌病杂志（中英文）》2023年第2期122-127,共6页Chinese Journal of Heart Failure and Cardiomyopathy

基　　金：2021年山西省基础研究计划(自由探索类)第二批项目(20210302123409)。

摘　　要：随着人口老龄化的加剧,心力衰竭(心衰)和肿瘤的发病率和患病率同时上升,成为全球死亡率最高的非传染性疾病。研究表明,心衰患者肿瘤发生风险增加,而肿瘤患者心衰发生风险亦显著增高,并且多种抗肿瘤治疗存在心脏毒性。本文将基于流行病学数据、基础及临床研究探讨心衰与肿瘤之间发生发展的关联机制,以期为二者的早期防治提供新思路。As the population ages,the incidence and prevalence of heart failure(HF)and tumors are increasing,making them the most deadly non-communicable diseases(NCDs)worldwide.Studies have shown that patients with HF are at increased risk of developing tumors,while patients with tumors are at significantly higher risk of developing HF,and various anti-neoplastic treatments are cardiotoxic.In this paper,we will investigate the mechanism of the association between HF and tumor development based on epidemiological data,basic and clinical studies,with the aim of providing new ideas for the early prevention and treatment of both.

关 键 词：心力衰竭 肿瘤 相关性 机制 

分 类 号：R541.6[医药卫生—心血管疾病] R730.5[医药卫生—内科学]